Idiopathic multicentric Castleman disease (iMCD)

If left untreated, iMCD can severely impact your health

Fight Back With SYLVANT
man-lymph-wall

Idiopathic multicentric Castleman disease (iMCD)

SYLVANT® (siltuximab) is the only FDA-approved treatment for iMCD

Learn More
campaign-woman-lymph-wall-2
mail-icon@2x

Insights on iMCD

Tips and tools delivered straight to your inbox

Sign Up
tips

Understanding
iMCD

Learn More

How SYLVANT
Can Help

Learn More

Patient
Connect

Learn More

Doctor
Discussion
Guide

Visit Now

Abbreviations: FDA, US Food and Drug Administration; iMCD, idiopathic multicentric Castleman disease.